In research models, its studied for its interaction with GHRH receptors on the pituitary gland, where it prompts the pituitary to release endogenous growth hormone through the bodys own regulatory pathway rather than introducing growth hormone directly, as some other compounds in this research category do
Results Disclaimer: Individual results vary and depend on multiple factors including adherence to treatment, provider guidance, diet, exercise, and individual health conditions
Haematological responses occur within 12 weeks, but nerve repair is slower and may be incomplete if deficiency has been prolonged
GHRPs (like GHRP-2 or GHRP-6) are often combined with CJC-1295 and are dosed at 100300 mcg per injection, typically one to three times daily
Your goal is to make dosing simple
Patients should always inform their healthcare provider about: A complete medical review helps reduce the risk of unexpected interactions and ensures treatment decisions are based on an individuals overall health profile